Articles

Glucocorticoids (GC) may expose patients to the risk of diabetes, particularly with long term use.

by Guest Writer Richard Purcell
More than 100 million U.S. adults are now living with diabetes or prediabetes, according to the Centers for Disease Control and Prevention.1 This epidemic requires new healthcare models to deliver optimal, patient-focused, guideline-directed care to improve outcomes and reduce costs. The establishment of a new multispecialty Managed Services Organization (MSO) in Arizona spotlights the numerous benefits, to patients and providers alike, of providing end-to-end healthcare services and disease management solutions for complex diabetes.

Flu season is upon us; what does that mean for patients with type 2 diabetes?

Does your ancestral origin determine your risk of developing type 1 diabetes?

A new study revealed that plasma aspartic acid and asparagine levels predict development of prediabetes; histidine plasma levels proved protective of prediabetes risk.  

Preserving beta cell function will maintain glucose homeostasis and may prevent diabetes.

A recent cross-sectional, cohort study found that too little or too much sleep is associated with higher HbA1c.

A furry or bluish tongue may indicate type 2 diabetes, according to a recent study.

Insulin resistance in adults with and without obesity, in current and former marijuana users.  

TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.